These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Differences in prolactin elevation and related symptoms of atypical antipsychotics in schizophrenic patients. Melkersson K J Clin Psychiatry; 2005 Jun; 66(6):761-7. PubMed ID: 15960571 [TBL] [Abstract][Full Text] [Related]
3. Prolactin levels in schizophrenia and schizoaffective disorder patients treated with clozapine, olanzapine, risperidone, or haloperidol. Volavka J; Czobor P; Cooper TB; Sheitman B; Lindenmayer JP; Citrome L; McEvoy JP; Lieberman JA J Clin Psychiatry; 2004 Jan; 65(1):57-61. PubMed ID: 14744169 [TBL] [Abstract][Full Text] [Related]
4. Antipsychotic medication, prolactin elevation, and ovarian function in women with schizophrenia and schizoaffective disorder. Canuso CM; Goldstein JM; Wojcik J; Dawson R; Brandman D; Klibanski A; Schildkraut JJ; Green AI Psychiatry Res; 2002 Aug; 111(1):11-20. PubMed ID: 12140115 [TBL] [Abstract][Full Text] [Related]
5. Clozapine and risperidone in chronic schizophrenia: effects on symptoms, parkinsonian side effects, and neuroendocrine response. Breier AF; Malhotra AK; Su TP; Pinals DA; Elman I; Adler CM; Lafargue RT; Clifton A; Pickar D Am J Psychiatry; 1999 Feb; 156(2):294-8. PubMed ID: 9989566 [TBL] [Abstract][Full Text] [Related]
6. Effects of aripiprazole on prolactin levels in subjects with schizophrenia during cross-titration with risperidone or olanzapine: analysis of a randomized, open-label study. Byerly MJ; Marcus RN; Tran QV; Eudicone JM; Whitehead R; Baker RA Schizophr Res; 2009 Feb; 107(2-3):218-22. PubMed ID: 19038534 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and tolerability of ziprasidone versus risperidone as augmentation in patients partially responsive to clozapine: a randomised controlled clinical trial. Zink M; Kuwilsky A; Krumm B; Dressing H J Psychopharmacol; 2009 May; 23(3):305-14. PubMed ID: 18562423 [TBL] [Abstract][Full Text] [Related]
8. Prevalence of hyperprolactinemia in schizophrenic patients treated with conventional antipsychotic medications or risperidone. Kinon BJ; Gilmore JA; Liu H; Halbreich UM Psychoneuroendocrinology; 2003 Apr; 28 Suppl 2():55-68. PubMed ID: 12650681 [TBL] [Abstract][Full Text] [Related]
9. Risperidone-induced hyperprolactinemia in adolescents: A case series. Madhusoodanan S; Moise D J Clin Psychiatry; 2006 Jul; 67(7):1110-3. PubMed ID: 16889455 [TBL] [Abstract][Full Text] [Related]
10. A double-blind controlled study of adjunctive treatment with risperidone in schizophrenic patients partially responsive to clozapine: efficacy and safety. Anil Yağcioğlu AE; Kivircik Akdede BB; Turgut TI; Tümüklü M; Yazici MK; Alptekin K; Ertuğrul A; Jayathilake K; Göğüş A; Tunca Z; Meltzer HY J Clin Psychiatry; 2005 Jan; 66(1):63-72. PubMed ID: 15669890 [TBL] [Abstract][Full Text] [Related]
11. Adjunctive aripiprazole in the treatment of risperidone-induced hyperprolactinemia: A randomized, double-blind, placebo-controlled, dose-response study. Chen JX; Su YA; Bian QT; Wei LH; Zhang RZ; Liu YH; Correll C; Soares JC; Yang FD; Wang SL; Zhang XY Psychoneuroendocrinology; 2015 Aug; 58():130-40. PubMed ID: 25981348 [TBL] [Abstract][Full Text] [Related]
12. Prolactin serum levels in paranoid versus nonparanoid male schizophrenia patients treated with risperidone. Segal M; Avital A; Derevenski A; Berstein S; Sandbank S; Weizman A Int Clin Psychopharmacol; 2007 Jul; 22(4):192-6. PubMed ID: 17519641 [TBL] [Abstract][Full Text] [Related]
13. Relation between serum prolactin levels and antipsychotic response to risperidone in patients with schizophrenia. Charan A; Shewade DG; Rajkumar RP; Chandrasekaran A Psychiatry Res; 2016 Jun; 240():209-213. PubMed ID: 27111215 [TBL] [Abstract][Full Text] [Related]
14. Effects of olanzapine on prolactin levels of female patients with schizophrenia treated with risperidone. Kim KS; Pae CU; Chae JH; Bahk WM; Jun TY; Kim DJ; Dickson RA J Clin Psychiatry; 2002 May; 63(5):408-13. PubMed ID: 12019665 [TBL] [Abstract][Full Text] [Related]
15. Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder. Volavka J; Czobor P; Sheitman B; Lindenmayer JP; Citrome L; McEvoy JP; Cooper TB; Chakos M; Lieberman JA Am J Psychiatry; 2002 Feb; 159(2):255-62. PubMed ID: 11823268 [TBL] [Abstract][Full Text] [Related]
16. [Plasma levels of antipsychotics and the severity of side-effects in the treatment of schizophrenia exacerbation]. Potanin SS; Burminskiy DS; Morozova MA; Platova AI; Baymeeva NV; Miroshnichenko II Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(11):40-46. PubMed ID: 26978050 [TBL] [Abstract][Full Text] [Related]
17. Risperidone versus clozapine in treatment-resistant chronic schizophrenia: a randomized double-blind study. The Risperidone Study Group. Bondolfi G; Dufour H; Patris M; May JP; Billeter U; Eap CB; Baumann P Am J Psychiatry; 1998 Apr; 155(4):499-504. PubMed ID: 9545995 [TBL] [Abstract][Full Text] [Related]
18. Effects of clozapine, olanzapine, risperidone, and haloperidol on hostility among patients with schizophrenia. Citrome L; Volavka J; Czobor P; Sheitman B; Lindenmayer JP; McEvoy J; Cooper TB; Chakos M; Lieberman JA Psychiatr Serv; 2001 Nov; 52(11):1510-4. PubMed ID: 11684748 [TBL] [Abstract][Full Text] [Related]
20. The effects of clozapine and risperidone on spatial working memory in schizophrenia. McGurk SR; Carter C; Goldman R; Green MF; Marder SR; Xie H; Schooler NR; Kane JM Am J Psychiatry; 2005 May; 162(5):1013-6. PubMed ID: 15863811 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]